Cytotoxic and Apoptotic Activities of Rhizopogon roseolus (Corda) Th.Fr. Extracts

Year 2020, Volume: 7 Issue: 1, 54 - 62, 20.03.2020

Erdi Can Aytar Ali Özmen

https://doi.org/10.21448/ijsm.675618

Cited By: 1

Abstract

Many species of mushrooms have been used since ancient times, especially in Asian countries, as a food supplement and in the medical field due to their different biological activities. Nowadays, especially in Japan, Korea and China, various mushroom extracts have been used as potential additives in chemotherapy and radiation treatments. In this study, anticancer activity and apoptotic effect of Rhizopogon roseolus were investigated. The methanol and water extracts of mushroom were tested against HL- 60 human cancer cell line. Antiproliferative effects of the extracts were evaluated by using MTT method and apoptosis and necrosis ratios of the cells treated with extracts were determined by using Hoechst/Propidium iodide (HO/PI) staining method. According to obtained data, antiprolifarative effect of the methanol extract was higher than water extract and this effect was a concentration depending manner. Both of the extracts were shown higher apoptotic effect than necrotic effect on the HL-60 cell line.

Keywords

Rhizopogon roseolus, Mushroom, Apoptosis, Cell culture, HL-60

Thanks

We thanks to Prof.Dr. Hasan Hüseyin Doğan for the mushroom identified.

References

• Feeney, M.J., Dwyer, J., Hasler-Lewis, C.M., Milner, J.A., Noakes, M., Rowe, S., Wach, M., et al. (2014). Mushrooms and Health Summit Proceedings. J. Nutr., 144(7), 1128-1136.
• Kalač, P. (2013). Chemical Composition and Nutritional Value of European Species of Wild Growing Mushrooms: A Review. Food Chem, 113, 9-16.
• Reisa, G.C.L., Custodioa, F.B., Botelhob, B.G., Guidic, L.R., Gloriaa, M.B.A. (2020). Investigation of Biologically Active Amines in Some Selected Edible Mushrooms. J. Food Compos. Anal., 86, 103375.
• Manninen, H., Rotola-Pukkila, M., Aisala, H., Hopia, A., Laaksonen, T. (2018). Free Amino Acids and 5′-Nucleotides in Finnish Forest Mushrooms. Food Chem., 247, 23-28.
• Roupas, P., Keogh, J., Noakes, M., Margetts, C., Taylor, P. (2012). The Role of Edible Mushrooms in Health: Evaluation of The Evidence. J. Funct. Foods, 4, 687-709.
• Mariga, A.M., Yang, W.J., Mugambi, D.K., Pei, F., Zhao, L., Shao, Y.N., Hu, Q. (2014). Antiproliferative and Immuno Stimulatory Activity of a Protein from Pleurotus eryngii. J Sci Food Agr., 94, 3152-3162.
• Sheu, F., Chien, P.J., Wang, H.K., Chang, H.H., Shyu, Y.T. (2007). New Protein PCiP from Edible Golden Oyster Mushroom (Pleurotus citrinopileatus) Activating Murine Macrophages and Splenocytes. J Sci Food Agr., 87, 1550-1558.
• Shang, H.M., Song, H., Xing, Y.L., Niu, S.L., Ding, G.D., Jiang, Y.Y., Liang, F. (2015). Effects of Dietary Fermentation Concentrate of Hericium caput-medusae (Bull.:Fr.) Pers. on Growth Performance, Digestibility, and Intestinal Microbiology and Morphology in Broiler Chickens. J Sci Food Agr., 96, 215-222.
• Osaki, K., Suyama, S., Sakuno, E., Ushijima, S., Nagasawa, E., Maekawa, N., Ishihara, A. (2019). Antifungal Activity of The Volatile Compound Isovelleral Produced by Ectomycorrhizal Russula Fungi Against Plant-Pathogenic Fungi. J. Gen. Plant Pathol., 85, 428-435.
• Wang, J.C., Hu, S.H., Liang, Z.C., Lee, M.Y. (2005). Antigenotoxicity of Extracts from Pleurotus citrinopileatus. J. Sci. Food Agr., 85, 770-778.
• Zhou, J., Chen, Y., Xin, M., Luo, Q., Gu, J., Zhao, M., Xu, X., et al. (2013). Structure Analysis and Antimutagenic Activity of a Novel Salt-Soluble Polysaccharide from Auricularia polytricha. J Sci Food Agr., 93, 3225-3230.
• Kim, S.H., Jakhar, R., Kang, S.C. (2015). Apoptotic Properties of Polysaccharide Isolated from Fruiting Bodies of Medicinal Mushroom Fomes fomentarius in Human Lung Carcinoma Cell Line. Saudi J. Biol. Sci., 22, 484-490.
• Opletal, L., Jahodar, L., Chobot, V., Zdansky, P., Lukes, J., Bratova, M., Solichova, D. et al. (1997). Evidence for The Antihyperlipidemic Activity of Edible Fungus Pleurotus ostreatu. Brit J Biomed Sci., 54, 240-243.
• Vaz, J.A., Barros, L., Martins, A., Santos-Buelga, C., Vasconcelos, M., Ferreira, I.C. (2011). Chemical Composition of Wild Edible Mushrooms and Antioxidant Properties of Their Water Soluble Polysaccharidic and Ethanolic Fractions. Food Chemistry, 126, 610-616.
• Han, E.H., Hwang, Y.P., Kim, H.G., Choi, J.H., Im, J.H., Yang, J.H., Lee, H.U. et al. (2011). Inhibitory Effect of Pleurotus eryngii Extracts on the Activities of Allergic Mediators in Antigen-Stimulated Mast Cells. Food Chem. Toxicol., 27, 1199-1128.
• Akata, I., Ergonul, B., Kalyoncu, F. (2012). Chemical Compositions and Antioxidant Activities of 16 Wild Edible Mushroom Species Grown in Anatolia. Int. J. Pharmacol., 8, 134-138.
• Patel, S., Goya, A. (2011). Functional Oligosaccharides: Production, Properties and Applications. World J Microb. Biot., 27, 1119-1128.
• Chowdhury, S., Shreya, D., Bhattacharjee, D., Saha, P.K., Mukherjee, S., Bhattacharyya, B.K. (2015). Prebiotics-clinical relevance. Indian J. Nat. Prod., 6, 91-97.
• Stojkovic, D., Smiljkovic, M., Ciric, A., Glamoclija, J., Van Griensven, L., Ferreira, I.C., Sokovic, M. (2019). An Insight into Antidiabetic Properties of Six Medicinal and Edible Mushrooms: Inhibition of α-amylase and α-glucosidase Linked to Type-2 Diabetes. S. Afr. J. Bot., 120,100-103.
• Jiang, S., Wang, S., Sun, Y., Zhang, Q. (2014). Medicinal Properties of Hericium erinaceus and Its Potential to Formulate Novel Mushroom-Based Pharmaceuticals. ‎Appl. Microbiol. Biotechnol., 98(18), 7661-7670.
• Chihara G, Hamuro J, Maeda Y, Arai Y, Fukuoka F (1970). Fractionation and Purification of The Polysaccharides with Marked Antitumor Activity, Especially Lentinan, from Lentinus edodes (Berk.) Sing. an Edible Mushroom. Canc. Res., 30(11), 2776-2781.
• Vogel, F.S., Kemper, L.A., McGarry, S.J., Graham, D.G. (1975). Cytostatic, Cytocidal and Potential Antitumor Properties of a Class of Quinoid Compounds, Initiators of the Dormant State in the Spores of Agaricus bisporus. Am. J. Pathol., 78(1), 33-48.
• Pietras, M. (2019). First Record of North American Fungus Rhizopogon pseudoroseolus in Australia and Prediction of Its Occurrence Based on Climatic Niche and Symbiotic Partner Preferences. Mycorrhiza, 29, 397-401.
• Molina, R., Trape, J.M. (1994). Biology of The Ectomycorrhizal Genus, Rhizopogon. I. Host associations, Host-Specificity and Pure Culture Syntheses. New Phytol., 126, 653-675.
• Smith, A.H., Zeller, S.M. (1966). A Preliminary Account of The North American Species of Rhizopogon. Memoirs of the New York Botanical Garden, 14, 178
• Miranda, F.E., Majada, J., Casares, A. (2017). Efficacy of Propidium Iodide and FUN-1 Stains for Assessing Viability in Basidiospores of Rhizopogon roseolus. Mycologia, 109(2), 350-358.
• Yamaç, M., Bilgili, F. (2006). Antimicrobial Activities of Fruit Bodies and/or Mycelial Cultures of Some Mushroom Isolates. Pharm. Biol., 44(9), 660-667.
• Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A., Jemal, A. (2018). GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin., 68, 394-424.
• Ferlay, J., Colombet, M., Soerjomataram, I., Mathers, C., Parkin, D.M., Pineros, M., Znaor, A. et al. (2019). Estimating the Global Cancer Incidence and Mortality in 2018: GLOBOCAN Sources and Methods. Int. J. Cancer, 144, 1941-1953.
• Cannon, C.A., Watson, L.K., Roth, M.T., LaVergne, S. (2014). Assessing the Learning Needs of Oncology Nurses. Clin. J. Oncol. Nurs., 18(5), 577-580.
• Çevik, A.B., Akinci, A.B., Bağlama, S.S. (2019). The Use of Complementary and Alternative Medicine Among Lymphoma and Cancer Patients with a Solid Tumor: Oncology Clinics at Northern and Southern Turkey. Complement. Ther. Med., 47, 102173.
• Asatiani, M.D., Sharvit, L., Barseghyan, G.S., Chan, J.S.L., Elisashvili, V., Wasser,S.P. (2018). Cytotoxic Activity of Medicinal Mushroom Extracts on Human Cancer Cells. SF Biotechnol Bioeng., 1(1), 1006.
• Vrba, J., Dolezel, P., Vicar, J., Modriansky, M., Ulrichova, J. (2008) Chelerythrine and Dihydrochelerythrine Induce G1 Phase Arrest and Bimodal Cell Death in Human Leukemia HL-60 Cells. Toxicol in Vitro, 22, 1008-1017.
• Grusch, M., Polgar, D., Gfatter, S., Leuhuber, K., Huettenbrenner, S., Leisser, C., Fuhrmann, G. et al. (2002). Maintenance of ATP Favours Apoptosis Over Necrosis Triggered by Benzamide Riboside. Cell Death Differ., 9, 169-178.
• Huettenbrenner, S., Maier, S., Leisser, C., Polgar, D., Strasser, S., Grusch, M., Krupiltza, G. (2003). The Evolution of Cell Death Programs as Prerequisites of Multicellularity. Mutat. Res., 543(3), 235-49.
• Russell, R., Paterson, M. (2006). Ganoderma - a Therapeutic Fungal Biofactory. Phytochemistry, 67, 1985-2001.
• Liu, X., Yuan, J.P., Chung, C.K., Chen, X.J. (2002). Antitumor Activity of The Sporoderm-Broken Germinating Spores of Ganoderma lucidum. Cancer Lett., 182,155-161.
• Min, B.S., Gao, J.J., Nakamura, N., Hattori, M. (2000). Triterpenes from The Spores of Ganoderma Lucidum and Their Cytotoxicity against Meth-A and LLC Tumor Cells. Chem. Pharm. Bull., 48, 1026-1033.
• Xie, Y.Z., Li, S.Z., Yee, A., La Pierre, D.P., Deng, Z.Q. Lee D.Y.,Wu , Q.P. et al. (2006). Ganoderma Lucidum Inhibits Tumour Cell Proliferation and Induces Tumour Cell Death. Enzyme Microb Tech., 40, 177-185.
• Huie, C.W., Di, X. (2004). Chromatographic and Electrophoretic Methods for Lingzhi Pharmacologically Active Components. J. Chromatogr. B., 812, 241-257.
• Hu, H., Shikahn, N., Yang, X., Lee, Y.S., Kang, K.S. (2002). Ganoderma lucidum Extract Induc Cell Cycle Arrest and Apoptosis in MCF-7 Human Breast Cancer Cell. Int. J. Cancer, 102, 250-253.
• Kim, K.C., Kim, J.S., Son, J.K.,Kim, I.G. (2007). Enhanced Induction of Mitochondrial Damage and Apoptosis in Human Leukemia HL-60 cells by the Ganoderma lucidum and Duchesnea chrysantha Extracts. Cancer Lett., 246, 210-217
• Liu, F., Luo, K., Yu, Z., Co, N., Wu, S., Wu, P., Fung, K. et al. (2009). Suillin from the Mushroom Suillus placidus as Potent Apoptosis Inducer in Human Hepatoma HepG2 Cells. Chem-Biol Interact., 181,168–174.
• Vaz, J.A., Ferreira, I.C., Tavares, C., Almedia, G.M., Martins, A., Vesconcelos, M. (2012). Suillus collinitus Methanolic Extract Increases P53 Expression and Causes Cell Cycle Arrest and Apoptosis in a Breast Cancer Cell Line. Food Chem., 135, 596–602.
• Santos, T., Tavares, C., Sousa, D., Vaz, J.A., Calhelha, R.C., Martins, A., Almeida, G.M., et al. (2013). Suillus luteus Methanolic Extract Inhibits Cell Growth and Proliferation of a Colon Cancer Cell Line. Food Res. Int., 53, 476-481.
• Friedman, M. (2015). Chemistry, Nutrition, and Health-Promoting Properties of Hericium erinaceus (lion’s mane) Mushroom Fruiting Bodies and Mycelia and Their Bioactive Compounds. J Agr Food Chem., 63, 7108-7123.
• Wu, J., Tokunaga, T., Kondo, M., Ishigami, K., Tokuyama, S., Suziki, T., Choi, J.H. et al. (2015). Erinaceolactones A to C, from the Culture Broth of Hericium erinaceus. J. Nat. Prod, 78, 155-158.
• Chen, L., Li, Z.H., Yao, Y., Peng, L., Huang, R. Feng, T., Liu, J.K. (2017). Isoindolinone-containing Meroterpenoids with α-glucosidase Inhibitory Activity from Mushroom Hericium caput-medusae. Fitoterapia, 122, 107-114.
• Zhang, Z., Liu, R.N., Tang, J., Zhang, Y., Yang, Y., Shang, X.D. (2015). A new diterpene from the fungal mycelia of Hericium erinaceus. Phytochem. Lett., 11, 151-156.
• Chen, L., Yao, J.N., Chen, H.P., Zhao, Z.Z., Li, Z.H., Feng, T., Liu, J.K. (2018). Hericinoids A‒C, Cyathane Diterpenoids From Culture of Mushroom. Hericium erinaceus. Phytochem. Lett., 27, 94-100.
• Lavi, I., Friesem, D., Geresh, S., Hadar, Y., Schwartz, B. (2006). An Aqueous Polysaccharide Extract from the Edible Mushroom Pleurotus ostreatus Induces Anti-Proliferative and Pro-Apoptotic Effects on HT-29 Colon Cancer Cells. Cancer Lett., 244, 61-70.